Is Johnson & Johnson a Good Stock to Buy?
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 8, 2013 - 9:55am
Johnson & Johnson (NYSE:JNJ) currently trades at 23 times trailing earnings, which we’d normally consider to be a bit high for a stable consumer health and healthcare company. Revenue was 7% higher in the third quarter of 2012 than in the same period in 2011. While earnings were down, that decrease was entirely due to [...]
Continue reading this article »
Share This Article: